COVID-19

October 1, 2021

VUMC research contributed to first COVID-19 pill now under review

Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.

By Bill Snyder
September 30, 2021

The COVID Mass Vaccination Site Team faced a daunting task – put 200,000 shots in arms in six months. The team never wavered.

The accomplishment earned the group the Elevate Team Award.

By Matt Batcheldor
Carla Bumbalough is featured in the campaign that’s designed to thank employees for their dedication to their patients and each other during challenging times.
September 29, 2021

Campaign thanks employees for their dedication to patients and each other

Vanderbilt Health has launched a brand communications campaign — called Caregivers Need Care, Too — designed to thank the workforce for their dedication to their patients and to each other during challenging times.

By VUMC News and Communications
September 27, 2021

Meeting a critical need

VUMC employees stepped up at last week’s blood drive to help address the current regional and national shortage of blood and blood products driven by the COVID-19 pandemic.

By VUMC News and Communications
Meg Rush, MD, MMHC, testifying before Congress on Sept. 22.
September 27, 2021

Rush testifies before Congress on pandemic’s impact on children

Vanderbilt’s Meg Rush, MD, MMHC, spoke to several members of Congress recently and painted a vivid picture of the toll the virus has taken on children in Tennessee and at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By Christina Echegaray
Tullahoma Mayor Ray Knowis reads the proclamation accompanied by VTHH’s Rich Ellis and Marilyn Smith, DNP, MSN, RN.
September 24, 2021

City of Tullahoma honors staff of Vanderbilt Tullahoma-Harton Hospital for pandemic care efforts

The City of Tullahoma presented a proclamation of thanks to the staff of Vanderbilt Tullahoma Harton Hospital for their dedicated effort to care for the community during the COVID-19 pandemic.

By VUMC News and Communications
September 23, 2021

From fantasy fiction to patient narratives, the power of storytelling drives Michelle Izmaylov

"If you just simply sit with someone and listen, you will learn incredible things”
By Emily Stembridge
September 23, 2021

Study tracks smell, taste loss associated with COVID

Vanderbilt researchers are studying ways to better evaluate and predict who is at risk of persistent smell and taste loss after COVID-19 infection.
By Emily Stembridge
September 22, 2021

Rounds: Hard conversations

By Doug Campbell
September 22, 2021

“Ultra-potent” antibody against COVID-19 variants isolated at VUMC

A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.
By Bill Snyder
September 15, 2021

Older age, chronic co-morbidities associated with more severe COVID disease in children

Vanderbilt research found that multiple factors are associated with the severity of COVID-19 disease in children, including older age and chronic co-morbidities such as obesity, diabetes and neurologic conditions.
By Jessica Pasley
September 8, 2021

IT transition a success at Vanderbilt Tullahoma-Harton Hospital

Multiple teams from across Vanderbilt University Medical Center recently led a transition of the clinical and information technology (IT) systems at Vanderbilt Tullahoma-Harton Hospital.
By Madison Agee
September 2, 2021

Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.
By Nancy Humphrey
1 … 9 10 11 12 13 … 40